Global Surgical Tumor Ablation Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 279603
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Surgical Tumor Ablation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Surgical Tumor Ablation market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Liver Cancer accounting for % of the Surgical Tumor Ablation global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Radiofrequency Ablation segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Surgical Tumor Ablation include Galil Medical, Misonix, HealthTronics, AngioDynamics, and Medtronic, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Surgical Tumor Ablation market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Radiofrequency Ablation

Microwave Ablation

Cryoablation

Others

Market segment by Application, can be divided into

Liver Cancer

Breast Cancer

Lung Cancer

Prostate Cancer

Others

Market segment by players, this report covers

Galil Medical

Misonix

HealthTronics

AngioDynamics

Medtronic

Boston Scientific Corporation

Medtronic

SonaCare Medical

EDAP TMS

NeuWave Medical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Surgical Tumor Ablation product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Surgical Tumor Ablation, with revenue, gross margin and global market share of Surgical Tumor Ablation from 2019 to 2022.

Chapter 3, the Surgical Tumor Ablation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Surgical Tumor Ablation market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Surgical Tumor Ablation research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Surgical Tumor Ablation

1.2 Classification of Surgical Tumor Ablation by Type

1.2.1 Overview: Global Surgical Tumor Ablation Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Surgical Tumor Ablation Revenue Market Share by Type in 2021

1.2.3 Radiofrequency Ablation

1.2.4 Microwave Ablation

1.2.5 Cryoablation

1.2.6 Others

1.3 Global Surgical Tumor Ablation Market by Application

1.3.1 Overview: Global Surgical Tumor Ablation Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Liver Cancer

1.3.3 Breast Cancer

1.3.4 Lung Cancer

1.3.5 Prostate Cancer

1.3.6 Others

1.4 Global Surgical Tumor Ablation Market Size & Forecast

1.5 Global Surgical Tumor Ablation Market Size and Forecast by Region

1.5.1 Global Surgical Tumor Ablation Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Surgical Tumor Ablation Market Size by Region, (2017-2022)

1.5.3 North America Surgical Tumor Ablation Market Size and Prospect (2017-2028)

1.5.4 Europe Surgical Tumor Ablation Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Surgical Tumor Ablation Market Size and Prospect (2017-2028)

1.5.6 South America Surgical Tumor Ablation Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Surgical Tumor Ablation Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Surgical Tumor Ablation Market Drivers

1.6.2 Surgical Tumor Ablation Market Restraints

1.6.3 Surgical Tumor Ablation Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Galil Medical

2.1.1 Galil Medical Details

2.1.2 Galil Medical Major Business

2.1.3 Galil Medical Surgical Tumor Ablation Product and Solutions

2.1.4 Galil Medical Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Galil Medical Recent Developments and Future Plans

2.2 Misonix

2.2.1 Misonix Details

2.2.2 Misonix Major Business

2.2.3 Misonix Surgical Tumor Ablation Product and Solutions

2.2.4 Misonix Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Misonix Recent Developments and Future Plans

2.3 HealthTronics

2.3.1 HealthTronics Details

2.3.2 HealthTronics Major Business

2.3.3 HealthTronics Surgical Tumor Ablation Product and Solutions

2.3.4 HealthTronics Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 HealthTronics Recent Developments and Future Plans

2.4 AngioDynamics

2.4.1 AngioDynamics Details

2.4.2 AngioDynamics Major Business

2.4.3 AngioDynamics Surgical Tumor Ablation Product and Solutions

2.4.4 AngioDynamics Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 AngioDynamics Recent Developments and Future Plans

2.5 Medtronic

2.5.1 Medtronic Details

2.5.2 Medtronic Major Business

2.5.3 Medtronic Surgical Tumor Ablation Product and Solutions

2.5.4 Medtronic Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Medtronic Recent Developments and Future Plans

2.6 Boston Scientific Corporation

2.6.1 Boston Scientific Corporation Details

2.6.2 Boston Scientific Corporation Major Business

2.6.3 Boston Scientific Corporation Surgical Tumor Ablation Product and Solutions

2.6.4 Boston Scientific Corporation Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Boston Scientific Corporation Recent Developments and Future Plans

2.7 Medtronic

2.7.1 Medtronic Details

2.7.2 Medtronic Major Business

2.7.3 Medtronic Surgical Tumor Ablation Product and Solutions

2.7.4 Medtronic Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Medtronic Recent Developments and Future Plans

2.8 SonaCare Medical

2.8.1 SonaCare Medical Details

2.8.2 SonaCare Medical Major Business

2.8.3 SonaCare Medical Surgical Tumor Ablation Product and Solutions

2.8.4 SonaCare Medical Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 SonaCare Medical Recent Developments and Future Plans

2.9 EDAP TMS

2.9.1 EDAP TMS Details

2.9.2 EDAP TMS Major Business

2.9.3 EDAP TMS Surgical Tumor Ablation Product and Solutions

2.9.4 EDAP TMS Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 EDAP TMS Recent Developments and Future Plans

2.10 NeuWave Medical

2.10.1 NeuWave Medical Details

2.10.2 NeuWave Medical Major Business

2.10.3 NeuWave Medical Surgical Tumor Ablation Product and Solutions

2.10.4 NeuWave Medical Surgical Tumor Ablation Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 NeuWave Medical Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Surgical Tumor Ablation Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Surgical Tumor Ablation Players Market Share in 2021

3.2.2 Top 10 Surgical Tumor Ablation Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Surgical Tumor Ablation Players Head Office, Products and Services Provided

3.4 Surgical Tumor Ablation Mergers & Acquisitions

3.5 Surgical Tumor Ablation New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Surgical Tumor Ablation Revenue and Market Share by Type (2017-2022)

4.2 Global Surgical Tumor Ablation Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Surgical Tumor Ablation Revenue Market Share by Application (2017-2022)

5.2 Global Surgical Tumor Ablation Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Surgical Tumor Ablation Revenue by Type (2017-2028)

6.2 North America Surgical Tumor Ablation Revenue by Application (2017-2028)

6.3 North America Surgical Tumor Ablation Market Size by Country

6.3.1 North America Surgical Tumor Ablation Revenue by Country (2017-2028)

6.3.2 United States Surgical Tumor Ablation Market Size and Forecast (2017-2028)

6.3.3 Canada Surgical Tumor Ablation Market Size and Forecast (2017-2028)

6.3.4 Mexico Surgical Tumor Ablation Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Surgical Tumor Ablation Revenue by Type (2017-2028)

7.2 Europe Surgical Tumor Ablation Revenue by Application (2017-2028)

7.3 Europe Surgical Tumor Ablation Market Size by Country

7.3.1 Europe Surgical Tumor Ablation Revenue by Country (2017-2028)

7.3.2 Germany Surgical Tumor Ablation Market Size and Forecast (2017-2028)

7.3.3 France Surgical Tumor Ablation Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Surgical Tumor Ablation Market Size and Forecast (2017-2028)

7.3.5 Russia Surgical Tumor Ablation Market Size and Forecast (2017-2028)

7.3.6 Italy Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Surgical Tumor Ablation Revenue by Type (2017-2028)

8.2 Asia-Pacific Surgical Tumor Ablation Revenue by Application (2017-2028)

8.3 Asia-Pacific Surgical Tumor Ablation Market Size by Region

8.3.1 Asia-Pacific Surgical Tumor Ablation Revenue by Region (2017-2028)

8.3.2 China Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8.3.3 Japan Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8.3.4 South Korea Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8.3.5 India Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Surgical Tumor Ablation Market Size and Forecast (2017-2028)

8.3.7 Australia Surgical Tumor Ablation Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Surgical Tumor Ablation Revenue by Type (2017-2028)

9.2 South America Surgical Tumor Ablation Revenue by Application (2017-2028)

9.3 South America Surgical Tumor Ablation Market Size by Country

9.3.1 South America Surgical Tumor Ablation Revenue by Country (2017-2028)

9.3.2 Brazil Surgical Tumor Ablation Market Size and Forecast (2017-2028)

9.3.3 Argentina Surgical Tumor Ablation Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Surgical Tumor Ablation Revenue by Type (2017-2028)

10.2 Middle East & Africa Surgical Tumor Ablation Revenue by Application (2017-2028)

10.3 Middle East & Africa Surgical Tumor Ablation Market Size by Country

10.3.1 Middle East & Africa Surgical Tumor Ablation Revenue by Country (2017-2028)

10.3.2 Turkey Surgical Tumor Ablation Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Surgical Tumor Ablation Market Size and Forecast (2017-2028)

10.3.4 UAE Surgical Tumor Ablation Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Surgical Tumor Ablation Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Surgical Tumor Ablation Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Surgical Tumor Ablation Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Surgical Tumor Ablation Revenue (USD Million) by Region (2017-2022)

Table 5. Global Surgical Tumor Ablation Revenue Market Share by Region (2023-2028)

Table 6. Galil Medical Corporate Information, Head Office, and Major Competitors

Table 7. Galil Medical Major Business

Table 8. Galil Medical Surgical Tumor Ablation Product and Solutions

Table 9. Galil Medical Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Misonix Corporate Information, Head Office, and Major Competitors

Table 11. Misonix Major Business

Table 12. Misonix Surgical Tumor Ablation Product and Solutions

Table 13. Misonix Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. HealthTronics Corporate Information, Head Office, and Major Competitors

Table 15. HealthTronics Major Business

Table 16. HealthTronics Surgical Tumor Ablation Product and Solutions

Table 17. HealthTronics Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. AngioDynamics Corporate Information, Head Office, and Major Competitors

Table 19. AngioDynamics Major Business

Table 20. AngioDynamics Surgical Tumor Ablation Product and Solutions

Table 21. AngioDynamics Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Medtronic Corporate Information, Head Office, and Major Competitors

Table 23. Medtronic Major Business

Table 24. Medtronic Surgical Tumor Ablation Product and Solutions

Table 25. Medtronic Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors

Table 27. Boston Scientific Corporation Major Business

Table 28. Boston Scientific Corporation Surgical Tumor Ablation Product and Solutions

Table 29. Boston Scientific Corporation Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Medtronic Corporate Information, Head Office, and Major Competitors

Table 31. Medtronic Major Business

Table 32. Medtronic Surgical Tumor Ablation Product and Solutions

Table 33. Medtronic Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. SonaCare Medical Corporate Information, Head Office, and Major Competitors

Table 35. SonaCare Medical Major Business

Table 36. SonaCare Medical Surgical Tumor Ablation Product and Solutions

Table 37. SonaCare Medical Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. EDAP TMS Corporate Information, Head Office, and Major Competitors

Table 39. EDAP TMS Major Business

Table 40. EDAP TMS Surgical Tumor Ablation Product and Solutions

Table 41. EDAP TMS Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. NeuWave Medical Corporate Information, Head Office, and Major Competitors

Table 43. NeuWave Medical Major Business

Table 44. NeuWave Medical Surgical Tumor Ablation Product and Solutions

Table 45. NeuWave Medical Surgical Tumor Ablation Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Global Surgical Tumor Ablation Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 47. Global Surgical Tumor Ablation Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 48. Breakdown of Surgical Tumor Ablation by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Surgical Tumor Ablation Players Head Office, Products and Services Provided

Table 50. Surgical Tumor Ablation Mergers & Acquisitions in the Past Five Years

Table 51. Surgical Tumor Ablation New Entrants and Expansion Plans

Table 52. Global Surgical Tumor Ablation Revenue (USD Million) by Type (2017-2022)

Table 53. Global Surgical Tumor Ablation Revenue Share by Type (2017-2022)

Table 54. Global Surgical Tumor Ablation Revenue Forecast by Type (2023-2028)

Table 55. Global Surgical Tumor Ablation Revenue by Application (2017-2022)

Table 56. Global Surgical Tumor Ablation Revenue Forecast by Application (2023-2028)

Table 57. North America Surgical Tumor Ablation Revenue by Type (2017-2022) & (USD Million)

Table 58. North America Surgical Tumor Ablation Revenue by Type (2023-2028) & (USD Million)

Table 59. North America Surgical Tumor Ablation Revenue by Application (2017-2022) & (USD Million)

Table 60. North America Surgical Tumor Ablation Revenue by Application (2023-2028) & (USD Million)

Table 61. North America Surgical Tumor Ablation Revenue by Country (2017-2022) & (USD Million)

Table 62. North America Surgical Tumor Ablation Revenue by Country (2023-2028) & (USD Million)

Table 63. Europe Surgical Tumor Ablation Revenue by Type (2017-2022) & (USD Million)

Table 64. Europe Surgical Tumor Ablation Revenue by Type (2023-2028) & (USD Million)

Table 65. Europe Surgical Tumor Ablation Revenue by Application (2017-2022) & (USD Million)

Table 66. Europe Surgical Tumor Ablation Revenue by Application (2023-2028) & (USD Million)

Table 67. Europe Surgical Tumor Ablation Revenue by Country (2017-2022) & (USD Million)

Table 68. Europe Surgical Tumor Ablation Revenue by Country (2023-2028) & (USD Million)

Table 69. Asia-Pacific Surgical Tumor Ablation Revenue by Type (2017-2022) & (USD Million)

Table 70. Asia-Pacific Surgical Tumor Ablation Revenue by Type (2023-2028) & (USD Million)

Table 71. Asia-Pacific Surgical Tumor Ablation Revenue by Application (2017-2022) & (USD Million)

Table 72. Asia-Pacific Surgical Tumor Ablation Revenue by Application (2023-2028) & (USD Million)

Table 73. Asia-Pacific Surgical Tumor Ablation Revenue by Region (2017-2022) & (USD Million)

Table 74. Asia-Pacific Surgical Tumor Ablation Revenue by Region (2023-2028) & (USD Million)

Table 75. South America Surgical Tumor Ablation Revenue by Type (2017-2022) & (USD Million)

Table 76. South America Surgical Tumor Ablation Revenue by Type (2023-2028) & (USD Million)

Table 77. South America Surgical Tumor Ablation Revenue by Application (2017-2022) & (USD Million)

Table 78. South America Surgical Tumor Ablation Revenue by Application (2023-2028) & (USD Million)

Table 79. South America Surgical Tumor Ablation Revenue by Country (2017-2022) & (USD Million)

Table 80. South America Surgical Tumor Ablation Revenue by Country (2023-2028) & (USD Million)

Table 81. Middle East & Africa Surgical Tumor Ablation Revenue by Type (2017-2022) & (USD Million)

Table 82. Middle East & Africa Surgical Tumor Ablation Revenue by Type (2023-2028) & (USD Million)

Table 83. Middle East & Africa Surgical Tumor Ablation Revenue by Application (2017-2022) & (USD Million)

Table 84. Middle East & Africa Surgical Tumor Ablation Revenue by Application (2023-2028) & (USD Million)

Table 85. Middle East & Africa Surgical Tumor Ablation Revenue by Country (2017-2022) & (USD Million)

Table 86. Middle East & Africa Surgical Tumor Ablation Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Surgical Tumor Ablation Picture

Figure 2. Global Surgical Tumor Ablation Revenue Market Share by Type in 2021

Figure 3. Radiofrequency Ablation

Figure 4. Microwave Ablation

Figure 5. Cryoablation

Figure 6. Others

Figure 7. Surgical Tumor Ablation Revenue Market Share by Application in 2021

Figure 8. Liver Cancer Picture

Figure 9. Breast Cancer Picture

Figure 10. Lung Cancer Picture

Figure 11. Prostate Cancer Picture

Figure 12. Others Picture

Figure 13. Global Surgical Tumor Ablation Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Surgical Tumor Ablation Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Surgical Tumor Ablation Revenue Market Share by Region (2017-2028)

Figure 16. Global Surgical Tumor Ablation Revenue Market Share by Region in 2021

Figure 17. North America Surgical Tumor Ablation Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Surgical Tumor Ablation Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Surgical Tumor Ablation Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Surgical Tumor Ablation Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Surgical Tumor Ablation Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Surgical Tumor Ablation Market Drivers

Figure 23. Surgical Tumor Ablation Market Restraints

Figure 24. Surgical Tumor Ablation Market Trends

Figure 25. Galil Medical Recent Developments and Future Plans

Figure 26. Misonix Recent Developments and Future Plans

Figure 27. HealthTronics Recent Developments and Future Plans

Figure 28. AngioDynamics Recent Developments and Future Plans

Figure 29. Medtronic Recent Developments and Future Plans

Figure 30. Boston Scientific Corporation Recent Developments and Future Plans

Figure 31. Medtronic Recent Developments and Future Plans

Figure 32. SonaCare Medical Recent Developments and Future Plans

Figure 33. EDAP TMS Recent Developments and Future Plans

Figure 34. NeuWave Medical Recent Developments and Future Plans

Figure 35. Global Surgical Tumor Ablation Revenue Share by Players in 2021

Figure 36. Surgical Tumor Ablation Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 37. Global Top 3 Players Surgical Tumor Ablation Revenue Market Share in 2021

Figure 38. Global Top 10 Players Surgical Tumor Ablation Revenue Market Share in 2021

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 40. Global Surgical Tumor Ablation Revenue Share by Type in 2021

Figure 41. Global Surgical Tumor Ablation Market Share Forecast by Type (2023-2028)

Figure 42. Global Surgical Tumor Ablation Revenue Share by Application in 2021

Figure 43. Global Surgical Tumor Ablation Market Share Forecast by Application (2023-2028)

Figure 44. North America Surgical Tumor Ablation Sales Market Share by Type (2017-2028)

Figure 45. North America Surgical Tumor Ablation Sales Market Share by Application (2017-2028)

Figure 46. North America Surgical Tumor Ablation Revenue Market Share by Country (2017-2028)

Figure 47. United States Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe Surgical Tumor Ablation Sales Market Share by Type (2017-2028)

Figure 51. Europe Surgical Tumor Ablation Sales Market Share by Application (2017-2028)

Figure 52. Europe Surgical Tumor Ablation Revenue Market Share by Country (2017-2028)

Figure 53. Germany Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific Surgical Tumor Ablation Sales Market Share by Type (2017-2028)

Figure 59. Asia-Pacific Surgical Tumor Ablation Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific Surgical Tumor Ablation Revenue Market Share by Region (2017-2028)

Figure 61. China Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South Korea Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Surgical Tumor Ablation Sales Market Share by Type (2017-2028)

Figure 68. South America Surgical Tumor Ablation Sales Market Share by Application (2017-2028)

Figure 69. South America Surgical Tumor Ablation Revenue Market Share by Country (2017-2028)

Figure 70. Brazil Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Argentina Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Middle East and Africa Surgical Tumor Ablation Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Surgical Tumor Ablation Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa Surgical Tumor Ablation Revenue Market Share by Country (2017-2028)

Figure 75. Turkey Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. UAE Surgical Tumor Ablation Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source